108 related articles for article (PubMed ID: 20584001)
1. Neutrophil-dominant experimental autoimmune uveitis in CC-chemokine receptor 2 knockout mice.
Sonoda KH; Yoshimura T; Egashira K; Charo IF; Ishibashi T
Acta Ophthalmol; 2011 Mar; 89(2):e180-8. PubMed ID: 20584001
[TBL] [Abstract][Full Text] [Related]
2. Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2.
Dagkalis A; Wallace C; Xu H; Liebau S; Manivannan A; Stone MA; Mack M; Liversidge J; Crane IJ
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4288-94. PubMed ID: 19357362
[TBL] [Abstract][Full Text] [Related]
3. The monocyte chemokine receptor CX3CR1 does not play a significant role in the pathogenesis of experimental autoimmune uveoretinitis.
Kezic J; McMenamin PG
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5121-7. PubMed ID: 20463325
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin is proinflammatory in experimental autoimmune uveitis.
Hikita ST; Vistica BP; Jones HR; Keswani JR; Watson MM; Ericson VR; Ayoub GS; Gery I; Clegg DO
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4435-43. PubMed ID: 17003437
[TBL] [Abstract][Full Text] [Related]
5. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice.
Keino H; Takeuchi M; Kezuka T; Yamakawa N; Tsukahara R; Usui M
Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):111-5. PubMed ID: 12605265
[TBL] [Abstract][Full Text] [Related]
6. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
7. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
Zhao J; Chen M; Xu H
Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
[TBL] [Abstract][Full Text] [Related]
8. Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice.
Oshima T; Sonoda KH; Tsutsumi-Miyahara C; Qiao H; Hisatomi T; Nakao S; Hamano S; Egashira K; Charo IF; Ishibashi T
Br J Ophthalmol; 2006 Feb; 90(2):218-22. PubMed ID: 16424537
[TBL] [Abstract][Full Text] [Related]
9. The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation.
Copland DA; Wertheim MS; Armitage WJ; Nicholson LB; Raveney BJ; Dick AD
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5458-65. PubMed ID: 18757507
[TBL] [Abstract][Full Text] [Related]
10. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of experimental autoimmune uveitis in mice treated with FTY720.
Commodaro AG; Peron JP; Lopes CT; Arslanian C; Belfort R; Rizzo LV; Bueno V
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2568-74. PubMed ID: 20019358
[TBL] [Abstract][Full Text] [Related]
12. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
[TBL] [Abstract][Full Text] [Related]
13. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
Butler TL; McMenamin PG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
[TBL] [Abstract][Full Text] [Related]
14. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
15. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
[TBL] [Abstract][Full Text] [Related]
17. Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands.
Guyver CJ; Copland DA; Calder CJ; Sette A; Sidney J; Dick AD; Nicholson LB
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2027-35. PubMed ID: 16639012
[TBL] [Abstract][Full Text] [Related]
18. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
Conrad SM; Strauss-Ayali D; Field AE; Mack M; Mosser DM
Infect Immun; 2007 Feb; 75(2):653-65. PubMed ID: 17088347
[TBL] [Abstract][Full Text] [Related]
19. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.
Yoshimura T; Sonoda KH; Miyazaki Y; Iwakura Y; Ishibashi T; Yoshimura A; Yoshida H
Int Immunol; 2008 Feb; 20(2):209-14. PubMed ID: 18156624
[TBL] [Abstract][Full Text] [Related]
20. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
